Bene Vobis Coconut MCT Oil 500 ml

The Bene Vobis Coconut MCT Oil dietary supplement is a high-quality product that is a source of valuable MCT oil derived from coconut. This oil is a treasure containing many active substances with health-beneficial properties, such as caproic, caprylic, capric, lauric, myristic, and palmitic acids. Bene Vobis's product has a simple composition, without additives, preservatives, flavor enhancers, or colorants.

MCTs are saturated medium-chain fats composed of 6 to 10 carbon atoms. They are mainly found in coconut. These fats are metabolized in the liver and are not absorbed in the intestine like other fats.

Caprylic acid, present in MCTs, may help reduce the sensation of hunger. It participates in the acylation of ghrelin, widely recognized as a hunger hormone due to its orexigenic effects. [1]

Medium-chain fatty acids contribute to reducing LDL levels and increasing HDL levels. This effect has been shown to be similar to that of olive oil[2]. [2]

MCT supplementation can improve cognitive functions. Caprylic acid has been shown to help restore cognitive functions in people who have experienced cognitive decline[3]. [3]

In conclusion, Bene Vobis MCT coconut oil is a high-quality product that provides valuable MCT coconut oil. This substance offers many health benefits. Bene Vobis's product has the advantage of a pure and simple composition, without any additives, and a convenient liquid form for use.

1 Lemarié F, Beauchamp E, Legrand P, Rioux V. Revisiting the metabolism and physiological functions of caprylic acid (C8:0) with special attention to ghrelin acylation. Biochimie. 2016 Jan;120:40-8. doi: 10.1016/j.biochi.2015.08.002. Epub 2015 Aug 4. PMID: 26253695.

2 St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52. doi: 10.1080/07315724.2008.10719737. PMID: 18845704; PMCID: PMC2874191.

3 Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31. PMID: 19664276; PMCID: PMC2731764.